The Radboud University Medical Center Study Fund aims to provide very promising students without sufficient financial means the opportunity to complete one of our master’s programme, and possibly enroll in the PhD programme afterwards.
Therefore, each academic year about 9 full scholarships (or more partial) are offered to our most excellent international (non-EEA) applicants for the Biomedical Sciences or Molecular Mechanisms of Disease Master’s programmes . Eligibility for a study fund scholarship depends on the interview results, the results from your previous education, and (if applicable) your work experience. Scholarship candidates usually rank among the best 5% of their class.
The Radboud University Medical Center Study Fund is always combined with the Radboud Scholarship Programme. Together the two scholarships cover all tuition fees and living expenses.
For 2018/2019 the Studyfund scholarship amounts to €12,620. The grant comprises of € 2,060 tuition fees (which will be paid directly to Radboud University) and € 10,560 living expenses (which will be paid to the student). For 2019/2020, these amounts will be adjusted to reflect changes in tuition fees and the requirements set by the Dutch Immigration Office. Please note no extra costs such as flight and travel are covered.
If you are a high-achieving student this scholarship provides financial support while you undertake a research degree in the area of biomedical engineering, image or signal processing.
Value and duration
The PhD scholarship top-up is valued at $10,000 per annum for three years, with a possible six month extension.
Masters by Research Scholarship
The Masters by Research scholarship top-up is valued at $10,000 per annum for two years.
Number of scholarships available
Two scholarships are available, one for a PhD student and one for a Masters by Research student.
The 2016 top-up scholarship is available to local or international students.
Applicants must meet the following eligibility criteria:
to have obtained a letter of offer for a Masters by Research or PhD degree at RMIT University in the School of Electrical and Computer Engineering by the closing date of 31 December 2016. Please refer to the instructions on how to apply for postgraduate research OR already hold an offer letter from RMIT to do a Masters by Research or a PhD in the School of Electrical and Computer Engineering
possess good fundamental knowledge in signal processing, experimental design or intelligent systems.
possess excellent mathematical skills (probability theory and statistics, algebra, complex analysis)
possess good programming skills in Matlab, C
should have good teamwork skills
should have good oral and written communication skills in English language.
Biomedical Engineering Scholarship 2013
The College will be offering a total of 7 scholarships worth £18,000 eachto students starting in 2013 on the new Biomedical Engineering undergraduate programme.
What is the Biomedical Engineering Scholarship?
The Biomedical Engineering scholarship will offer a £6,000 fee waiver for each year of study (years 1 – 3) to successful applicants. This represents a total scholarship worth £18,000.
For Home and EU students this means that tuition fees for each of your first three years will be just £3,000 (subject to slight inflationary increase each subsequent year).
For international students, this will be a reduction in your tuition fees of £6,000 for each of your first three years.
Am I eligible to apply?
Biomedical Engineering Scholarships will be open to all applicants who hold an offer a place on the BEng programme at King’s starting in 2013.
BRUNEI DARUSSALAM GOVERNMENT SCHOLARSHIPS TO FOREIGN STUDENTS
TENABLE IN BRUNEI DARUSSALAM FOR THE 2013/2014 ACADEMIC SESSION
With His Majesty the Sultan and Yang Di-Pertuan of Brunei Darussalam’s consent, the Government of Brunei Darussalam is offering annual scholarships under a special scholarship award scheme, for the 2013/2014 academic session.
Tenable in Brunei Darussalam, the aim of the scholarship awards is to provide applicants, with the opportunity to study at Universiti Brunei Darussalam [UBD], Universiti Islam Sultan Sharif Ali [UNISSA] and Institut Teknologi Brunei [ITB].
The academic year for UBD, UNISSA and ITB commences in July / August 2013.
Hardiman Scholarships will be available for new PhD students commencing in September, 2013. These scholarships are fully-funded for 4 years, with a stipend of €16,000 p.a. plus fees.
The Hardiman Scholarships offer opportunities for suitably qualified individuals to pursue a Structured PhD focused on the five key areas of research in which the University offers leading expertise. These are:
Biomedical Science and Engineering
Informatics, Physical, and Computational Sciences
Environment, Marine, and Energy
Applied Social Sciences and Public Policy
Humanities in Context
Additional Cancer Care West Hardiman Scholarships will be available in cancer research with the generous support of Cancer Care West and Galway University Foundation. The scholarships will support translational and clinical research in the area of Cancer Biology, Therapeutics, and Psycho-oncology at NUI Galway and the associated University Hospital Galway (UHG).
The International Office is pleased to announce two £4,000 scholarships are available for successful applicants entering one of the specified postgraduate taught Masters programmes listed below. Scholarships will take the form of a £4,000 reduction in tuition fees.
To be considered for the scholarship:
Applicants must be deemed self-financing non-EU full overseas fee payers.
Applicants must hold a conditional or unconditional offer for one of the specified postgraduate taught Masters programmes listed below commencing at Aston University October 2012.
Applicants must submit an application in the form of a 500 word essay outlining why they would benefit from the scholarship and the difference it would make to them as well as why they would be a suitable person to work with the International Office to share their experiences at the University and help promote Aston to future students.
The successful scholars will be required to sign an agreement with the Aston University International Office to share their experiences of application, arrival, studying at Aston, lecturers and lectures, and student life. They will work with the International Office to provide information which can be used for promotional purposes, as well as regularly update a blog, which has to be created from the beginning of an academic year at Aston. The work will be used across the University including the School of study and the Development & Alumni Relations Office.
Our research group is working on cell-cell adhesion in health and disease, including evolutionary developmental biology (Evo-Devo). We are seeking a highly motivated Ph.D. student to perform research on the molecular evolution and the structures and functions of various cadherin superfamily members in key model organisms ranging from Placozoa and Cnidaria to mammals. The successful candidate will work in a small team and his/her research will involve a wide range of techniques: bioinformatics, recombinant DNA technology, gene and protein expression, targeted gene knockdown, phenotypic analysis, and advanced microscopy. Part of the research will be performed in laboratories outside Belgium.
You have a keen interest in phylogenomics, molecular cell biology, developmental biology and Evo-Devo questions.
You work diligently and accurately; you have a sense of responsibility and are eager to learn.
You read and speak scientific English fluently and you have good communication skills.
You are mobile and ready to perform long-term experiments abroad.
Last application date: 2011-12-20 12:00 Department: WE14 – Department of Biomedical molecular biology Degree: Master in Biotechnology-Biochemistry, Master in Biology, Master in Biomedical Sciences, Bioengineer, or equivalent degree with distinction
Invasive growth of a tumor occurs within an ecosystem where a continuous communication exists between cancer cells and a wide network of tumor-associated myofibroblasts. Secretory factors from the cancer cells activate the recruitment of myofibroblasts, both near to and far from the primary tumor site, as well as they promote the departure of cancer cells and myofibroblast precursors (such as bone marrow-derived mesenchymal stem cells, MSC) to distant tissues (FASEBJ 2004; JNCI 2010; Cancer Res 2010).
There is no doubt that preoperative radio(chemo)therapy may increase life expectancy however tumors recurring within a previously irradiated field are associated with higher risk of metastasis and poorer prognosis compared with recurrences outside the irradiated area. This is a clinically relevant situation because 10% to 20% of the patients treated with radiotherapy will relapse within the irradiated field and progress to form metastases. The goal of this research project will be to elucidate whether radiotherapy-induced changes in tumor-associated myofibroblasts affect cancer invasion and metastasis by using different molecular techniques in a colorectal cancer model.
We offer a stimulating environment for the scientific development of the candidate. Through support of senior PhD students and post-doctoral scientists and close interaction with clinicians (department of surgery, radiotherapy, oncology), the candidate will be able to finalize a PhD thesis independently (in +/-4 years). The project and candidate is funded by BOF (Bijzonder OnderzoeksFonds) and VLK (Vlaamse Liga tegen Kanker)
Interested candidates preferentially have a degree of master in the biotechnology, biomedical sciences, bio-engineering, medical doctor or an equivalent degree. They have obtained good study results (at least distinction) during their education and they show a genuine interest and motivation to perform scientific research.
Our research team focuses on genetic and functional studies to identify and evaluate novel genes that are implicated in T-cell acute lymphoblastic leukemia (T-ALL). We have recently identified PHF6 as a novel tumor suppressor gene in T-ALL (Nature Genetics, 2010) and are currently evaluating its functional role. We also wish to evaluate the functional role of other, non-coding genes (miRNAs, lncRNAs) that might be implicated in T-ALL development. We therefore aim to develop a novel zebrafish model to study these T-ALL genes.
In recent years, zebrafish have emerged as a potent model organism to study hematological diseases and can be easily modified genetically and used in large screens with compounds that might be of benefit in leukemia treatment. In these model systems, a broad variety of morphological studies in combination with different molecular-biological techniques (RNAi, overexpression, reporter assays, miRNA/mRNA expression profiling…) will be applied. Moreover, multiple transgenic zebrafish lines can be crossed with each other to study collaborating genes in T-ALL development and can thus be utilized in chemical screens to identify novel potential molecular compounds for T-ALL therapy.
The candidate will be prepared to apply for grant proposals (IWT, FWO, or other), although there are possibilities to prolong the candidate’s contract in case of project disapproval. We offer a stimulating environment to perform top scientific research and support by postdoctoral scientists and PhD students involved in T-ALL research and zebrafish models. The candidate is motivated to work towards a final PhD thesis.
Background: master in biomedical sciences / biotechnology / biochemistry / pharmaceutical sciences / medicine (MD); bio-engineer (cell and gene technology) or equivalent; high grades are certainly recommended; experience with in vivo models is a plus but not required
The American Indonesia Exchange Foundation (AMINEF) is pleased to announce the availability of approximately 40 awards to be competed worldwide under the aegis of International Fulbright Science and Technology Award for Ph.D. study at top U.S. institutions in science, technology, or engineering for the 2012-2013 academic year matriculants.
The Fulbright Program in Indonesia promotes mutual understanding between the Republic of Indonesia and the United States of America through educational exchange and academic scholarship. Fulbright scholarships for this particular program are available to Indonesian citizens with the appropriate qualifications as stipulated below.
ELIGIBILITY & REQUIREMENTS
Applicants will possess:
a Bachelor and/or Master’s degree with a minimum GPA of 3.0 (on a 4.00 scale).
Undergraduate students who will complete the degree before August 1, 2011 may also apply.
demonstrated leadership qualities.
a good understanding of Indonesian and other cultures.
a deep commitment to the chosen field of study.
a determination to return to Indonesia upon completion of the Fulbright program.
a minimum institutional TOEFL score of 580 or IELTS 6.5 or higher at the time of application.
a minimum GRE quantitative score of 700 (GRE test will be required if selected for nomination).